RNU2-57P

Across TCGA pan-cancer cohorts, RNU2-57P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU2-57P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU2-57P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU2-57P expression acts as an unfavorable survival marker, although some lineages such as ESCA and GBM show a favorable association.

LIHC, ESCA, and BLCA are the cancer types where RNU2-57P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.118	0.783	<.001	54	view →
ESCA	OS	Tertile	III,IV	0.897	0.373	.018	48	view →
BLCA	OS	Tertile	IV	0.143	0.604	<.001	39	view →
UCS	DFS	Tertile	All	0.136	0.523	.034	18	view →
GBM	OS	Tertile	All	0.472	0.237	.019	15	view →
SARC	OS	Tertile	All	0.197	0.605	.006	15	view →
LAML	DFS	Tertile	All	1.000	0.351	.039	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU2-57P–LIHC (OS)

Open the LIHC breakdown →